Recently, some cases of ALPS, termed Type II and ALPS-like disease have been shown to be due to mutations in caspases 10 and 8, respectively; these are downstream signaling molecules in the Fas pathway [8-13]. The gene discussed is CASP10; the disease is autoimmune lymphoproliferative syndrome.